checkAd

    EANS-Voting Rights  557  0 Kommentare Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act - Seite 2


    | | | |Number of voting | |
    | | | | rights that may | |
    | | | | be | |
    | Type of |Expiration Date|Exercise Period|acquired if the | % of voting |
    | instrument | | | instrument is | rights |
    | | | | exercised | |
    |_____________|_______________|_______________|_________________|______________|
    | | | SUBTOTAL B.1 | | |
    |_____________|_______________|_______________|_________________|______________|


    _____________________________________________________________________________
    |B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG |
    |2018 |
    |_____________________________________________________________________________|
    | Type of | Expiration | Exercise | Physical / | Number of |% of voting |
    |instrument | Date | Period | Cash |voting rights| rights |
    |___________|____________|___________|_Settlement__|_____________|____________|
    | | | |SUBTOTAL B.2 | | |
    |___________|____________|___________|_____________|_____________|____________|


    8. Information in relation to the person subject to the notification obligation:
    Person subject to the notification obligation is not controlled by any natural
    person or legal entity and does not control any other undertaking(s) holding
    directly or indirectly an interest in the (underlying) issuer.

    9. In case of proxy voting
    Date of general meeting: -
    Voting rights after general meeting: - is equivalent to - voting rights.

    10. Additional comments:
    The voting rights held by Erste Asset Management GmbH as stated in section 8 are
    not held directly but by the investment funds managed by the management company.
    They are therefore not holdings of the management company.

    Note of the Issuer: This is a translation of the received shareholder
    notification in German language. The translation into English is not binding.



    Further inquiry note:

    Dr. Eva Prieschl-Grassauer
    Chief Scientific Officer, Marinomed
    Veterinärplatz 1, 1210 Vienna, Austria
    T +43 (0)1 250 77 4460
    E-Mail: eva.prieschl@marinomed.com
    http://www.marinomed.com

    Roland Mayrl
    Managing Partner, Metrum Communications
    Bauernmarkt 10/19, 1010 Vienna, Austria
    T +43 (0) 1 504 69 87 331
    E-Mail: r.mayrl@metrum.at
    http://www.metrum.at

    end of announcement euro adhoc
    --------------------------------------------------------------------------------

    issuer: Marinomed Biotech AG
    Veterinärplatz 1
    A-1210 Wien
    phone: 0043250774460
    FAX: 0043250774493
    mail: office@marinomed.com
    WWW: www.marinomed.com
    ISIN: ATMARINOMED6, AT0000A1WD52
    indexes:
    stockmarkets: Wien
    language: English


    Seite 2 von 2


    Diskutieren Sie über die enthaltenen Werte


    news aktuell
    0 Follower
    Autor folgen

    Verfasst von news aktuell
    EANS-Voting Rights Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act - Seite 2 - Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement. - Overview 1. Issuer: Marinomed Biotech AG 2. Reason for the notification: …

    Schreibe Deinen Kommentar

    Disclaimer